- Joined
- Jan 5, 2010
- Messages
- 2,097
- Points
- 83
The reason for excessive healthcare costs inflation in the world.
Pharma companies and new medtech companies pocket most of the increase with new and better products to prolong life.
Most new products just delay the inevitable, but those with medical insurance with full riders demand the best because '$$$ no-issue', everything covered by blank cheque from insurance.
People who need 100% nursing assistance and used to die in weeks-months now STILL NEED 100% assistance but take years to die, thanks to TLC or new inventions that don't really make an old sick person much stronger/ healthier (maybe a bit better) but costs a bomb to obtain/prescribe.
New cancer immunotherapy chemotherapy (SGD20,000/mth) is more effective but mostly cannot cure patient, so patient has to take meds for life or untill ineffective wherein which case, hopefully a new option (even more expensive) can be found.
As long as FDA approves, share price of healthcare tech company will increase and everyone along the gravy chain from lab scientist to CEO to hospital staff will get pay/ dividend $$$ increase.
Thus, the marginal health benefit is not worth the increase healthcare costs but desperate people will pay any price... This is the reason for runaway inflation in healthcare costs in most places in the world.
Pharma companies and new medtech companies pocket most of the increase with new and better products to prolong life.
Most new products just delay the inevitable, but those with medical insurance with full riders demand the best because '$$$ no-issue', everything covered by blank cheque from insurance.
People who need 100% nursing assistance and used to die in weeks-months now STILL NEED 100% assistance but take years to die, thanks to TLC or new inventions that don't really make an old sick person much stronger/ healthier (maybe a bit better) but costs a bomb to obtain/prescribe.
New cancer immunotherapy chemotherapy (SGD20,000/mth) is more effective but mostly cannot cure patient, so patient has to take meds for life or untill ineffective wherein which case, hopefully a new option (even more expensive) can be found.
As long as FDA approves, share price of healthcare tech company will increase and everyone along the gravy chain from lab scientist to CEO to hospital staff will get pay/ dividend $$$ increase.
Thus, the marginal health benefit is not worth the increase healthcare costs but desperate people will pay any price... This is the reason for runaway inflation in healthcare costs in most places in the world.
